Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

Clarion Managing Director & Founder, Bart Lombardi, to Moderate Panel at CBI's Bio/Pharmaceutical Product Commercialization and Launch Roadmap in Boston, MA


Clarion, a life sciences strategy and organizational consultancy, today announced that Managing Director and Founder, Bart Lombardi will moderate a panel at CBI's 5th Annual Bio/Pharmaceutical Product Commercialization and Launch Roadmap on Evolving Go-To-Market Strategies for Successful New Product Launch in 2020 & Beyond. The panel, which will include senior pharmaceutical industry executives, will take place on Tuesday, October 29, 2019 at 10:30am at the DoubleTree Suites in Boston.

Bart Lombardi has over 20 years of experience in corporate and portfolio strategy, new product launches, commercialization strategy, indication prioritization, managed care strategy, and BD&L strategy. Working across the spectrum from emerging biotech to Fortune 100 companies, Lombardi and the Clarion team understand the challenges and opportunities afforded by the continuously evolving health system landscape and the value of working closely with leadership teams to deliver the promise of innovation.

About Clarion

Clarion is a life sciences strategy and organizational consultancy that works together with its clients to envision, craft, and enable growth through innovation and leadership. Across therapeutic categories, Clarion collaborates deeply with its clients to tackle their most complex cross-functional business challenges and decisions throughout the product and company lifecycle. With over 15 years of unparalleled experience in new product commercialization, Clarion partners with leaders in the biopharma industry to guide strategic decision-making necessary to launch a first asset or expand an existing portfolio. For more information, please visit www.clarionhealthcare.com.

About CBI

CBI, an Informa business, is the health and life sciences industry leader in providing thought leadership, actionable data, benchmarking, case studies and regulatory information through a dynamic conference platform that facilitates innovation, collaboration and elevation across the pharmaceutical, biotechnology, medical device and healthcare industries. CBI's proprietary and intensive market research and product feasibility testing methodology has helped CBI deliver timely and first to market content driven conferences. For more information, please visit www.cbinet.com.


These press releases may also interest you

at 10:15
The Micro-electro-mechanical System (MEMS) market is projected to grow from USD 16.5 billion in 2024 and is estimated to reach USD 24.2 billion by 2029; it is expected to grow at a Compound Annual Growth Rate (CAGR) of 7.9% from 2024 to 2029...

at 10:12
NerdsToGo®, a leading information technology (IT) solutions and technology repair services franchise for both business and home, announced today plans for its strategic expansion throughout the greater Chicago area with 20 new territories available...

at 10:11
TeachTown, a leading provider of special education curriculum for students with moderate to severe disabilities, is pleased to announce that its K-12 standards-based, adapted core curriculum, enCORE, has been named a finalist in 2 categories of the...

at 10:05
The "Distribution Deals in Diagnostics 2016 to 2024" report has been added to ResearchAndMarkets.com's offering. Distribution Deals in Diagnostics provides a detailed understanding and analysis of how and why companies enter distribution deals....

at 10:01
The Predictive Maintenance Market is estimated to grow from USD 10.6...

at 10:00
Frost & Sullivan recently researched the customer experience outsourcing services industry and, based on its findings, recognizes AeC with the 2023 Company of the Year Award. AeC is connecting technology with outstanding customer service to increase...



News published on and distributed by: